Epoprostenol was developed and is marketed in the United States by Gilead Sciences, and marketed elsewhere by GlaxoSmithKline.
Epoprostenol was developed. Epoprostenol is marketed in the United States by Gilead Sciences. Epoprostenol marketed elsewhere by GlaxoSmithKline.